Crescentic IgA nephropathy after administration of human monoclonal interleukin-12/23p40 antibody in a patient with Crohn’s disease: a case report

Ustekinumab (UST), an interleukin (IL)-12/IL-23-blocking monoclonal antibody, is a novel therapeutic option for Crohn’s disease (CD). We describe a 24-year-old man with CD who showed an abrupt decline in renal function after administration of UST. Twenty-nine months previously, the patient was diagn...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:CEN Case Rep
Hlavní autoři: Kanazawa, Nobuhiro, Wada, Yukihiro, Akiyama, Minako, Shikida, Yasuto, Sugiyama, Motonori, Abe, Maki, Iyoda, Masayuki, Honda, Kazuho, Shibata, Takanori
Médium: Artigo
Jazyk:Inglês
Vydáno: Springer Singapore 2020
Témata:
Case Report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7320091/
https://ncbi.nlm.nih.gov/pubmed/32100251
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13730-020-00457-x
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky